Muhammad Waqas Sadiq

Years Active: 2021-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, Ian C Scott, Adam Williams, Lisa Hewitt, Nicholas White, Helen Killick, Monica Gavala, E Suzanne Cohen, Fred Reid, Chris Kell, Hitesh Pandya, Eulalia Jimenez
Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease. British journal of clinical pharmacology (2024)
Muhammad Waqas Sadiq, Sara Asimus, Maria G Belvisi, Wayne Brailsford, Rebecca Fransson, Rainard Fuhr, Anette Hagberg, Mahdi Hashemi, Tina Jellesmark Jensen, Julia Jonsson, Christina Keen, Thomas Körnicke, Cecilia Kristensson, Jukka Mäenpää, Sofia Necander, Szilárd Nemes, Joanne Betts
Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease. British journal of clinical pharmacology (2021)
Muhammad Waqas Sadiq, Olaf Holz, Birthe D Ellinghusen, Cornelia Faulenbach, Meike Müller, Philipp Badorrek, Ulf G Eriksson, Markus Fridén, Stina Stomilovic, Anders J Lundqvist, Jens M Hohlfeld
Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation. British journal of pharmacology 178 (22) (2021)

Muhammad Waqas Sadiq.css-eqlu8i{font-size:small;padding-left:4px;}